These results strongly suggest that diosbulbin C may induce G0/G1 phase cell cycle arrest and inhibit NSCLC cell proliferation by downregulating the expression/activation of AKT, DHFR, and TYMS in NSCLC cells. Here, AKT1 is linked to non-small cell lung carcinoma.